My NCBISign In
A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis
A Mark Fendrick, Bruce P Greenberg
Osteopath Med Prim Care. 2009; 3: 1. Published online 2009 January 6. doi: 10.1186/1750-4732-3-1
PMCID:
PMC2646740
Abstract Full Text PDF–240K

Is Cited by the Following 4 Articles in this Archive:

The impact of antiplatelet therapy on pelvic fracture outcomes
Jonathan M Christy, S Peter Stawicki, Amy M Jarvis, David C Evans, Anthony T Gerlach, David E Lindsey, Peggy Rhoades, Melissa L Whitmill, Steven M Steinberg, Laura S Phieffer, Charles H Cook
J Emerg Trauma Shock. 2011 Jan-Mar; 4(1): 64–69. doi: 10.4103/0974-2700.76841
PMCID:
PMC3097583
Abstract Full Text
Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping
Meiping Chang, Sarah Smith, Andrew Thorpe, Michael J Barratt, Farzana Karim
Mol Pain. 2010; 6: 56. Published online 2010 September 16. doi: 10.1186/1744-8069-6-56
PMCID:
PMC2949723
Abstract Full Text PDF–676K
Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004–2008 – a retrospective patient record review
Metha Brattwall, Ibrahim Turan, Jan Jakobsson
J Pain Res. 2010; 3: 131–135. Published online 2010 August 4.
PMCID:
PMC3004648
Abstract Full Text PDF–165K
Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-α and matrix metalloproteinase-13 in human chondrocytes
Zafar Rasheed, Arivarasu N Anbazhagan, Nahid Akhtar, Sangeetha Ramamurthy, Frank R Voss, Tariq M Haqqi
Arthritis Res Ther. 2009; 11(3): R71. Published online 2009 May 15. doi: 10.1186/ar2700
PMCID:
PMC2714117
Abstract Full Text PDF–1.0M
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk